4//SEC Filing
Insys Therapeutics, Inc. 4
Accession 0001209191-15-039907
CIK 0001516479operating
Filed
May 6, 8:00 PM ET
Accepted
May 7, 4:05 PM ET
Size
5.3 KB
Accession
0001209191-15-039907
Insider Transaction Report
Form 4
Babich Michael L
DirectorPresident and CEO
Transactions
- Award
Stock Option (right to buy)
2015-05-05+60,000→ 60,000 totalExercise: $53.50Exp: 2025-05-04→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The option vests in 48 equal monthly installments and will be fully vested and exercisable on May 5, 2019.
Documents
Issuer
Insys Therapeutics, Inc.
CIK 0001516479
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001516479
Filing Metadata
- Form type
- 4
- Filed
- May 6, 8:00 PM ET
- Accepted
- May 7, 4:05 PM ET
- Size
- 5.3 KB